Obesity

Researchers study efficacy and safety of GLP-1 inhibitors on weight loss.

New study focuses on cardiovascular safety of weight loss drug in patients with excess weight or obesity.

Patient is male, 48 years of age, type 2 diabetes with hyperglycemia for eight years, class III obesity,  and very symptomatic GERD. Patient planned to have laparoscopic sleeve gastrectomy. I asked him why he chose that particular surgery. He said, "Because it's less invasive." I asked if his surgeon told him the sleeve gastrectomy could increase his GERD, and is not as effective for the treatment of type 2 diabetes nor for weight loss as is a bypass. He said, "No, the surgeon just left it to my choice. I said I wanted the sleeve and he was good with that."

Study shows mice with obesity and type 2 have significantly slower healing of wounds compared to those with undisturbed sleep.

When combined with diet and exercise, GLP-1 medication showed significant weight loss compared to liraglutide and placebo, a new study finds.

In part 2 of this Exclusive Interview, Rhoda Cobin talks with Diabetes in Control Medical Editor Joy Pape about the impact of obesity on PCOS.

Scott Isaacs, M.D., F.A.C.P., F.A.C.E. is a board-certified endocrinologist and obesity medicine specialist in Atlanta, Georgia, and a faculty member at Emory University School of Medicine. He is a medical expert for ABC Television Networks and the medical director for the HMR Program for Weight Management at Atlanta Endocrine Associates. Since 1998, Dr. Isaacs has focused his medical practice on obesity medicine and endocrinology. Dr. Isaacs attended Emory College and Emory University School of Medicine, continuing for his residency in Internal Medicine and Fellowship in Endocrinology, Lipids, Diabetes and Metabolism. Dr. Isaacs is a Fellow of the American College of Physicians and the American College of Endocrinology.  Dr. Isaacs is past president of the Georgia Chapter of the American Association of Clinical Endocrinologists and currently serves on the national AACE board of directors and chairs the patient education and awareness committee. Dr. Isaacs is past president of the Atlanta Chapter of the Atlanta Diabetes Association.

In this Exclusive Interview, Scott Isaacs talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston about the use of meal replacements in the treatment of obesity.

In part 1 of this Exclusive Interview, Scott Isaacs talks with Diabetes in Control Medical Editor Joy Pape about effectiveness of meal replacements and ongoing strategies for maintaining weight loss.

In part 2 of this Exclusive Interview, Scott Isaacs talks with Diabetes in Control Medical Editor Joy Pape about the difference between low calorie and very low calorie diets using meal replacements.